Wen Jianxin, vice chairman of Shenzhen Pingshan District CPPCC, led a team to investigate Shenzhen Cell Valley
On October 17, Wen Jianxin, vice chairman of the CPPCC, led a research team composed of Hu Xiaobing, director of the Economic Committee of the CPPCC, Gu Peng, member of the CPPCC, Shen Xing, Li Huihua, Meng Xian, and Tang Yonghe, deputy director of the CPPCC Affairs Center, to conduct an in-depth investigation of Shenzhen Cell Valley. Professor Shi Yuanyuan, chairman of Shenzhen Cell Valley, Dr. Fu Yuchen, assistant to the chairman, and Wang Lu, director of the general Office warmly received and held the symposium.
Research team led a line in the history of origin chairman visited the wisdom, the company's strategic development layout, enterprise development, the history of cell therapy, service platform construction and enterprise vision have a preliminary understanding, and the valley of Shenzhen cells from basic scientific research to clinical application of all-round, one-stop service process has a deeper understanding.
During the symposium, we and the research team discussed the current situation of IIT application and the specific situation of CRO / CDMO services in the field of cell and gene therapy. History history chairman mentioned, our company from the original CRO / CDMO one-stop outsourcing service to focus on cell and gene therapy one-stop solution service, is due to deep the CGT field demand for producer services not only covers the CRO and CDMO services, more extended to quality control and guarantee services, supply chain management services, and regulations and clinical trial consulting, and other key links, including each link is crucial, these services together, together constitute the complete system from the laboratory to the market. While ensuring the quality and compliance of products, it significantly reduces the burden of production problems in clinical practice, effectively reduces the research and development and labor costs of enterprises, so as to truly realize the new technology of cell therapy to benefit the people and promote the vigorous development of the whole industry.
Chairman of Shenzhen cell valley strategic layout and enterprise vision gave high uation, and emphasizes the core of the research purpose is to deeply analyze the plateau mountain area CGT industry latest trends and development trend, aims to accurately grasp the industry dynamics, for the plateau mountain cell therapy products dual-track management strategy optimization provide solid theoretical support and practical basis, and for related enterprises to create more superior policy environment, promote the stable development of plateau mountain CGT industry.
At the end of the symposium, both sides hope to jointly promote the vigorous development of the whole industry and accelerate the pace of technological innovation through the close cooperation between the government and enterprises, in order to realize the more rapid and efficient entry into the market stage of cell therapy drugs, and contribute to the sustainable development of the industry.
Chairman of Shenzhen cell valley strategic layout and enterprise vision gave high uation, and emphasizes the core of the research purpose is to deeply analyze the plateau mountain area CGT industry latest trends and development trend, aims to accurately grasp the industry dynamics, for the plateau mountain cell therapy products dual-track management strategy optimization provide solid theoretical support and practical basis, and for related enterprises to create more superior policy environment, promote the stable development of plateau mountain CGT industry.
At the end of the symposium, both sides hope to jointly promote the vigorous development of the whole industry and accelerate the pace of technological innovation through the close cooperation between the government and enterprises, in order to realize the more rapid and efficient entry into the market stage of cell therapy drugs, and contribute to the sustainable development of the industry.
